The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC).
 
Danny Rischin
Research Funding - Amgen; Bristol-Myers Squibb; Genentech/Roche; Merck; Regeneron
 
Michael Robert Migden
Honoraria - Novartis; Regeneron; Sun Pharma
Consulting or Advisory Role - Novartis; Regeneron; Sun Pharma
Research Funding - Novartis (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Regeneron; Sun Pharma
 
Anne Chang
Research Funding - Merck; Novartis
 
Christine H. Chung
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Lilly; Vigilant Biosciences
Research Funding - AstraZeneca; Bristol-Myers Squibb; Ignyta; IRX Therapeutics; Lilly; Lion Biotechnologies; Merck; Pfizer; Regeneron
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Lilly
 
Lara Dunn
Research Funding - Pfizer; Regeneron
 
Alexander Guminski
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Merck; MSD; Pfizer; Sun Pharma
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Sun Pharma
 
Axel Hauschild
Honoraria - Amgen; Bristol-Myers Squibb; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar; Novartis; OncoSec; Philogen; Provectus; Regeneron; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar; Novartis; OncoSec; Philogen; Provectus; Regeneron; Roche
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; Merck Serono; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar; Novartis; OncoSec; Philogen; Provectus; Regeneron; Roche
 
Leonel Hernandez-Aya
Consulting or Advisory Role - Massive Bio
Research Funding - Bristol-Myers Squibb (Inst); Immunocore (Inst); Merck Serono (Inst); Regeneron (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche
 
Karl D. Lewis
Research Funding - Regeneron
 
Annette May Ling Lim
No Relationships to Disclose
 
Badri Modi
Employment - City of Hope
 
Dirk Schadendorf
Honoraria - 4SC; Agenus; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Grunenthal; Immunocore; Incyte; LEO Pharma; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pfizer; Philogen; Pierre Fabre; Regeneron; Roche/Genentech; Sysmex
Consulting or Advisory Role - 4SC; Amgen; Bristol-Myers Squibb; Immunocore; Incyte; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Incyte; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche/Genentech
 
Chrysalyne Schmults
Honoraria - Regeneron
Consulting or Advisory Role - Castle Biosciences; Regeneron
Research Funding - Castle Biosciences; Genentech; Novartis; Regeneron
 
Jocelyn Booth
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Siyu Li
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Kosalai Kal Mohan
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Elizabeth Stankevich
Employment - Regeneron
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene; Merck; Regeneron
 
Israel Lowy
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Matthew G. Fury
Employment - Regeneron; Regeneron (I)
Stock and Other Ownership Interests - Regeneron; Regeneron (I)
Consulting or Advisory Role - Egenix
Research Funding - AstraZeneca/MedImmune; Novartis; Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron (I)